Rybelsus Rybelsus (semaglutide) is an oral GLP-1 medicatoin and an alternative to Ozempic
Least-squares mean percentage changes in body weight at week 48 were 8.7% (1 mg), 17.1% (4 mg), 22.8% (8 mg), and 24.2% (12 mg), compared with 2.1% in the placebo arm
Romagnani, P
A higher CFU count is generally better, but it's also important to choose strains that have been clinically shown to be effective for your specific needs
Practical shake characteristics to consider: Lower-fat formulas Avoiding highly acidic mix-ins (large amounts of citrus, very tart berries) Moderate portions, sipped slowly Some people also find that a shake is more comfortable as a smaller snack rather than a large meal replacement, especially late in the evening
While TIR has demonstrated efficacy in mitigating cognitive impairments associated with diabetes and in reducing cardiotoxicity induced by DXN, it has not been effective in addressing cognitive dysfunction specifically resulting from DXN exposure (Guo et al., 2023
